Wholesale Korea Juvelook Ha 200mg Pdlla Lenisna Is Designed as a Time-Acting Filler with a Concentration Collagen Powerfill PLA +Ha Biostimulator Etrebelle

• Certification: FDA, CE
• Disinfection: Disinfection
• Color: Transparent
• Application: Body Face
• Material: Power
• Transport Package: Paper Box
• Model NO.: 50mg Olidia Lenisna 200mg
• Specification: Juvelook50mg
• Trademark: JUVELOOK
• Origin: Korea
• Production Capacity: 50000

Product Description

Key Specifications/ Special Features:

 

 

Juvelook is a hybrid filler that combines both the benefits of an immediate filling effect, resulting from the use of HA hyal uronic acid, and long-term stimulation of collagen production, thanks to the use of polylactic acid PDLLA (Poly D, L - lactide)

Thanks to the patented production technology, a preparation with unique properties has been created: long-term effectiveness and an increased safety profile.

Intended use:

• Shadows under the eyes
• Volume loss in the lower eyelid area
• Marked valley of tears
• Flaccidity of the skin of the neck, skin of the hands, skin of the face
• Brightening and firming the skin
• Rejuvenation of the eye area
• Wrinkle smoothing
• Permanent tension and nourishment of the skin

Areas of application:

• eye area: lower eyelid, crow's feet, tear trough
• forehead
• skin mesoth erapy: face, neck and cleavage

Therapy effects

The effects of therapy are visible immediately after administration. We obtain the effect of filling thanks to the presence of hyal uronic acid. After about 2 weeks, collagen production begins with the presence of PDLLA lactic acid microparticles. The effects of the therapy last for more than two years after the last treatment. The recommended number of treatments is 2 or 3 depending on the skin defect at 6-8 week intervals. After two years, it is recommended to perform 1 booster treatment.

Injection methods:

It is administered with a thin 27 g cannula in the area of the lower eyelid or with thin needles, e.g. 31 G, making injections into the lower part of the dermis to a depth of about 1.7 mm.

Strengths of JUVELOOK:

• the world's only Poly D,L Lactyd + HA hybrid formula with a particle size of 10 to 40 microns
• effectiveness and safety confirmed by clinical trials
• durability of the effects - more than 2 years from the last treatment

 

 

• immediate effect - due to hyaluronic acid
• safety - FDA, CE certificates for polylactic acid
• patents and own clinical trials
• particle size from 10 to 40 microns
• comfort of the procedure - ease of injection and no needle clogging during the procedure

Composition

• Polylactic acid (PDLLA - Poly D, L Lactyd) 42.5 mg (particle size 10-40 microns)
• Non-crosslinked hyalur onic acid 7.5mg (particle size 3000kDa)

Product for use by professionals only.
By deciding to purchase, you declare that you are a doctor or cosmetologist trained in aesthetic medicine

korea AestheFill Aesthe Fill 4D Poly L Lactic Acid PLLA Injection D ermal fill er for face

 

 

 

Description

 

Botul inum tox in type A (Nab ta) is indicated for the temporary treatment of glabellar lines associated with cardboard lines and / or decreased abdominal muscle activity in adult patients less than 65 years of age. B toxin type A (Nabta) is indicated for the treatment of focal armpit hyperhidrosis.

Description

toxin type A (Nab ta) is indicated for the temporary improvement in the appearance of the upper respiratory tract (forehead lines, crow's feet and forehead lines) in adults.  toxin type A (Nabta) is indicated for the prevention of headaches in adults with chronic migraine.

toxin type A (Nab ta) is indicated for the treatment of urinary incontinence due to neurogenic detrusor overactivity, e.g., spinal cord injury (SCI) or multiple sclerosis (MI) in adults.

INDICATION

• Temporary improvement in the appearance of moderate to severe glabellar lines associated with ripple and / or lower abdominal activity in adult patients
• Treatment of upper limb spasticity in adult patients
• Transient improvement in the appearance of moderate to severe lateral angular lines associated with ocular activity in adult patients
• Treatment of dystonia-related blepharospasm in adult patients
• HI Pure TM technology

Composition: volume - 100 units

The package includes a glass ampoule in which the powder is placed under pressure. Sometimes the ampoule may seem empty. For use, dilute the powder in the ampoule with saline. For 100 units, add 2.5 ml of saline, for 200 units - 5 ml of saline.